´ç´¢º´ °ü·Ã Á¶»çº¸°í¼¿¡¼´Â ´ç´¢º´ °ü·Ã Á¦Ç° ½ÃÀåÀÇ Ãֽе¿Çâ¿¡ ´ëÇØ Æø³Ð°Ô ´Ù·ç¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¡·á¹ý°ú Àν¶¸°, Àν¶¸° Àü´Þ ½Ã½ºÅÛ, ¿ªÇÐÀû »óȲ, ȯÀÚ Àα¸ ¹× ¿¬·É ±¸Á¶, À¯º´ÀÚ¼ö, °Ë»ç ¹æ¹ý µî¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. °¢±¹ ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ Àü¸Á¿¡ °üÇÑ º¸°í¼µµ ´Ù¼ö ±¸ºñÇϰí ÀÖ½À´Ï´Ù.
![]() |
¼Ò¾Æ ´ç´¢º´ °ü¸® ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Á¦Ç°º°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Pediatric Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By End User, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ °æ±¸ Ç×´ç´¢º´¾à ½ÃÀå
Oral Anti-Diabetic Drugs
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ Àΰ£ ÀçÁ¶ÇÕ Àν¶¸° ½ÃÀå
Human Recombinant Insulin
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ±âÃÊ Àν¶¸° ½ÃÀå
Basal Insulin
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¼³Æ÷´Ò¿ä¼Ò ½ÃÀå
Sulfonylureas
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´¼º ÄÉÅæ»êÁõ(DKA) Ä¡·á ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Ä¡·á À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅà Äɾî), Áö¿ªº°, °æÀï(2020-2030³â)
Diabetic Ketoacidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings), By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Ä¡·áº°, ±Ë¾ç À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÎ¹®, °æÀï(2020-2030³â)
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment, By Ulcer Type, By End User, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ Â÷¼¼´ë ´ç´¢º´ Ä¡·á ¹× ¾à¹°Àü´Þ ½ÃÀå
Next Generation Diabetes Therapy and Drug Delivery
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¹«¹Ù´Ã ´ç´¢º´ Ä¡·á ½ÃÀå
Needle Free Diabetes Care
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
´ç´¢º´¼º ±Ë¾ç Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Ç° À¯Çüº°, ±Ë¾ç À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°-»ê¾÷ ¿¹Ãø 2025-2032³â
Diabetic Ulcer Treatment Market Size, Share, and Growth Analysis, By Product Type (Wound Care Dressings, Wound Care Devices), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,300
![]() |
![]() |
´ç´¢º´ Ä¡·á ±â±â ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 4,850
![]() |
![]() |
GLP-1 ÀÛ¿ëÁ¦ ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2034³â) : À¯Çü, Á¦Ç°, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ÄÄÆ÷³ÍÆ®, ÀåÄ¡, Àü°³, ´Ü°è, ¼Ö·ç¼Ç
GLP-1 Agonist Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Component, Device, Deployment, Stage, Solutions
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 4,750
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´ Äɾî¿ë µð¹ÙÀ̽º ½ÃÀå
Diabetes Care Devices
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´ Ä¡·á¿ë ÀÓ»ó ¿µ¾çÇÐ ½ÃÀå
Clinical Nutrition for Diabetes Care
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´ ÀüÁõ ½ÃÀå
Prediabetes
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå
Insulin Injection Aids
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀå º¸°í¼ : À¯Çüº°, Ä¡·á À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Diabetic Retinopathy Market Report by Type, Treatment Type, End-User (Hospitals and Pharmacies, Eye Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 2,999
![]() |
![]() |
¼¼°èÀÇ ¸®¶ó±Û·çƼµå ¹× ¼¼¸¶±Û·çƼµå ½ÃÀå
Liraglutide and Semaglutide
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´¼º ±Ë¾ç Ä¡·á ½ÃÀå
Diabetic Ulcers Treatment
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´¼º ½Å°æÀå¾Ö °ü¸® ½ÃÀå
Diabetic Neuropathy Management
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ Á¦2Çü ´ç´¢º´ Ä¡·á ½ÃÀå
Type 2 Diabetes Mellitus Treatment
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
´ç´¢º´¼º ÄÉÅæ»êÁõ Ä¡·á ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)
Diabetic Ketoacidosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 4,850
![]() |
![]() |
¼¼°èÀÇ Àν¶¸° ¾Æ½ºÆÄ¸£Æ® ½ÃÀå : Á¦Çüº°, ÀûÀÀÁõº°, °µµº°, ¿¬·ÉÃþº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°
Insulin Aspart Market, By Dosage Forms, By Indication, By Strength, By Age Group, By End User, By Distribution Channel, By Geography
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ ¼Ò¾Æ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå
Pediatric Diabetes Therapeutics
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ´ç´¢º´ ÀüÁõ ½ÃÀå : Ä¡·á ¹× °ü¸®º°, ¼ºº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, üÁß Ä«Å×°í¸®º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2032³â)
Prediabetes Market, By Treatment & Management, By Gender, By Age Group, By Distribution Channel, By Weight Category, By End User, By Geography
¹ßÇà 2025³â 07¿ù
°¡°Ý
US $ 4,500
![]() |